Senior insider sale
PTC THERAPEUTICS, INC. — senior position signals high conviction
$6.96M
100K shares
SCHMERTZLER MICHAEL plans to sell 100K shares of PTC THERAPEUTICS, INC. valued at approximately $6.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Automatic Conversion of Preferred Stock into Common Stock Upon IPO
Automatic Conversion of Preferred Stock into Common Stock upon IPO (Preferred Stock acquired from Issuer for cash)
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2013 | Automatic Conversion of Preferred Stock into Common Stock Upon IPO Automatic Conversion of Preferred Stock into Common Stock upon IPO (Preferred Stock acquired from Issuer for cash) | 10K | — |
| Total | 10K | ||
Completed
Units to sell
10K
Market value
$678.5K
Units to sell
10K
Market value
$671.2K
Units to sell
10K
Market value
$673.4K
Units to sell
10K
Market value
$678.4K
Units to sell
12.50K
Market value
$894.8K
Units to sell
12.50K
Market value
$911.7K
Units to sell
12.50K
Market value
$888.9K
Units to sell
12.50K
Market value
$916.6K
Planned — Approximate Date
Units to sell
10K
Market value
$643.5K
Units
100K
Value
$6.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/17/2026 | 10K | $678.5K | — | Completed |
9/16/2026 | 10K | $671.2K | — | Completed |
9/10/2026 | 10K | $673.4K | — | Completed |
9/9/2026 | 10K | $678.4K | — | Completed |
8/27/2026 | 12.50K | $894.8K | — | Completed |
8/26/2026 | 12.50K | $911.7K | — | Completed |
8/20/2026 | 12.50K | $888.9K | — | Completed |
8/19/2026 | 12.50K | $916.6K | — | Completed |
| Planned — Approximate Date | ||||
10/7/2026 | 10K | $643.5K | NASDAQ | Planned |
| Total | 100K | $6.96M | ||